Cutting-edge triple-drug therapies for leukemia discussed at the American Society of Hematology meeting show promising results in achieving remission and managing residual disease.
In a first-of-its-kind analysis of radiological data, researchers found transgender women sustained 141 injuries versus 98 in controls, with significantly higher rates of facial, cranial, and thoracic injuries.
A study presented at RSNA 2024 demonstrated findings at midlife, decades prior to patients exhibiting early symptoms of Alzheimer's disease related dementia.